The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID-19 who have mild symptoms and face a high risk of hospitalization.

Canada and Mexico stave off tariffs on billions of dollars of materials crucial to the U.S. homebuilding industry President Trump walked back his decision to impose 25% tariffs on goods imported from ...

Among high-risk patients, treatment with paxlovid reduces the COVID-19 burden. Researchers conducted a phase 2/3, double-blind, randomized study (Evaluation of Protease Inhibition for COVID-19 in High ...

Paxlovid, one of the most well-known treatments for COVID-19, has also been shown to ease symptoms of some patients with long COVID — and new research suggests the antiviral medication could ...

Follow-up rates were similar in the treated and untreated groups, with slightly more adverse events demonstrated in the Paxlovid vs control group. Researchers conducted a retrospective electronic ...

The swift and unlikely ascent of the nation’s second largest mortgage brokerage, Loan Factory Inc., is owed to its founder and CEO Thuan Nguyen, whose harrowing journey to America shows why the ...